Par Drugs And Chemicals Limited (PAR) - Total Assets
Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) holds total assets worth Rs1.28 Billion INR (≈ $13.79 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Par Drugs And Chemicals Limited's book value for net asset value and shareholders' equity analysis.
Par Drugs And Chemicals Limited - Total Assets Trend (2016–2025)
This chart illustrates how Par Drugs And Chemicals Limited's total assets have evolved over time, based on quarterly financial data.
Par Drugs And Chemicals Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Par Drugs And Chemicals Limited's total assets of Rs1.28 Billion consist of 46.0% current assets and 54.1% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 23.1% |
| Accounts Receivable | Rs168.13 Million | 14.1% |
| Inventory | Rs61.06 Million | 5.1% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Par Drugs And Chemicals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Par Drugs And Chemicals Limited.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Par Drugs And Chemicals Limited's current assets represent 46.0% of total assets in 2025, an increase from 25.2% in 2016.
- Cash Position: Cash and equivalents constituted 23.1% of total assets in 2025, up from 1.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 14.1% of total assets.
Par Drugs And Chemicals Limited Competitors by Total Assets
Key competitors of Par Drugs And Chemicals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910
|
Korea | ₩344.02 Billion |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA
|
India | Rs525.46 Billion |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
|
China | CN¥56.56 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332
|
China | CN¥7.26 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Zhejiang Cheng Yi Pharmaceutical Co Ltd
SHG:603811
|
China | CN¥1.69 Billion |
|
Hainan Honz Pharmaceutical Co
SHE:300086
|
China | CN¥1.88 Billion |
Par Drugs And Chemicals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.57 | 3.20 | 2.44 |
| Quick Ratio | 3.26 | 2.87 | 2.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs449.22 Million | Rs337.10 Million | Rs190.89 Million |
Par Drugs And Chemicals Limited - Advanced Valuation Insights
This section examines the relationship between Par Drugs And Chemicals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.04 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 17.5% |
| Total Assets | Rs1.19 Billion |
| Market Capitalization | $12.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values Par Drugs And Chemicals Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Par Drugs And Chemicals Limited's assets grew by 17.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Par Drugs And Chemicals Limited (2016–2025)
The table below shows the annual total assets of Par Drugs And Chemicals Limited from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs1.19 Billion ≈ $12.91 Million |
+17.50% |
| 2024-03-31 | Rs1.02 Billion ≈ $10.99 Million |
+14.34% |
| 2023-03-31 | Rs888.68 Million ≈ $9.61 Million |
+12.93% |
| 2022-03-31 | Rs786.90 Million ≈ $8.51 Million |
+3.02% |
| 2021-03-31 | Rs763.84 Million ≈ $8.26 Million |
+27.06% |
| 2020-03-31 | Rs601.15 Million ≈ $6.50 Million |
+17.06% |
| 2019-03-31 | Rs513.55 Million ≈ $5.55 Million |
-4.79% |
| 2018-03-31 | Rs539.39 Million ≈ $5.83 Million |
-3.75% |
| 2017-03-31 | Rs560.41 Million ≈ $6.06 Million |
-3.43% |
| 2016-03-31 | Rs580.31 Million ≈ $6.28 Million |
-- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more